13 patents
Utility
Methods for the synthesis of deuterated dextromethorphan
19 Dec 23
Matt Johnson, Cunxiang Zhao, Weihua Meng, Zhijun Lu, Yan Li
Filed: 11 Nov 20
Utility
Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor
13 Jul 23
During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control and/or higher mental functioning, when they receive a combination of dextromethorphan and quinidine, at suitable dosages.
Richard A. SMITH
Filed: 19 Aug 22
Utility
Methods of Treating Negative Symptoms of Schizophrenia Using Deuterated Dextromethorphan and Quinidine
10 Mar 22
The present disclosure relates to methods of treating negative symptoms of schizophrenia.
Sanjay DUBÉ
Filed: 17 Sep 21
Utility
Methods for the Synthesis of Deuterated Dextromethorphan
4 Mar 21
Matt Johnson, Cunxiang Zhao, Weihua Meng, Zhijun Lu, Yan Li
Filed: 11 Nov 20
Utility
Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor
14 Jan 21
During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control and/or higher mental functioning, when they receive a combination of dextromethorphan and quinidine, at suitable dosages.
Richard A. SMITH
Filed: 2 Jan 20
Utility
Methods for the synthesis of deuterated dextromethorphan
14 Dec 20
The application describes methods for making a deuterated dextromethorphan of Formula (I), deuterated dextromethorphan produced by these methods, and pharmaceutically acceptable salts thereof.
Matt Johnson, Cunxiang Zhao, Weihua Meng, Zhijun Lu, Yan Li
Filed: 23 Jun 20
Utility
Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor
2 Dec 20
During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control and/or higher mental functioning, when they receive a combination of dextromethorphan and quinidine, at suitable dosages.
Richard A. SMITH
Filed: 1 Jan 20
Utility
Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Depression, Anxiety, and Neurodegenerative Disorders
25 Nov 20
Pharmaceutical compositions and methods for treating depression, anxiety, and neurodegenerative diseases and cognitive disorders, such as dementia and Alzheimer's disease, by administering same are provided.
James BERG
Filed: 22 Dec 19
Utility
Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Agitation In Dementia
11 Nov 20
This disclosure provides pharmaceutical compositions comprising dextromethorphan in combination with quinidine, and methods for treating agitation and/or aggression in subjects with dementia by administering such compositions.
Joao SIFFERT, James BERG
Filed: 10 Dec 19
Utility
Methods for the Synthesis of Deuterated Dextromethorphan
7 Oct 20
Matt Johnson, Cunxiang Zhao, Weihua Meng, Zhijun Lu, Yan Li
Filed: 23 Jun 20
Utility
Pharmaceutical Compositions Comprising a Dextromethorphan Compound and Quinidine for the Treatment of Agitation In Dementia
16 Sep 20
The present disclosure is related to methods of treating agitation and/or aggression and/or associated symptoms in subjects with dementia, including, dementia associated with Alzheimer's disease.
Joao SIFFERT
Filed: 7 Oct 19
Utility
Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
2 Sep 20
Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided.
Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
Filed: 2 Oct 19
Utility
Methods for the synthesis of deuterated dextromethorphan
3 Aug 20
Matt Johnson, Cunxiang Zhao, Weihua Meng, Zhijun Lu, Yan Li
Filed: 2 Jul 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first